4-Fluoroselegiline | |
---|---|
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 205.27 g/mol [1] |
Predicted LogP | 2.9 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C13H16FN [1] |
IUPAC name | (2R)-1-(4-fluorophenyl)-N-methyl-N-prop-2-ynylpropan-2-amine [1] |
SMILES | C[C@H](CC1=CC=C(C=C1)F)N(C)CC#C [1] |
InChI | InChI=1S/C13H16FN/c1-4-9-15(3)11(2)10-12-5-7-13(14)8-6-12/h1,5-8,11H,9-10H2,2-3H3/t11-/m1/s1 [1] |
InChIKey | MUDUXRHPVDVWHU-LLVKDONJSA-N [1] |
4-Fluoroselegiline
4-Fluoroselegiline (also known as p-Fluoro-L-deprenyl, Fludepryl, parafluoro-selegiline, Benzeneethanamine, 4-fluoro-N,α-dimethyl-N-2-propyn-1-yl-, (αR)- or Benzeneethanamine, 4-fluoro-n,α-dimethyl-n-2-propyn-1-yl-, (αr)-) is a monoamine oxidase inhibitor and prodrug substance of the amphetamine class.
Chemistry
Stereochemistry []
4-Fluoroselegiline is a absolute mixture
Pharmacology
4-Fluoroselegiline acts as a prodrug for:
Active metabolites [] |
---|
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 9794264, 4-Fluoroselegiline. Accessed July 20, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/9794264
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 4-Fluoroselegiline. UNII: 6U6PT7CR42. Global Substance Registration System. Accessed July 20, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6U6PT7CR42